The short version of Synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-16. Anything still debated is marked as such rather than presented as settled.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Approximate, for sequence GEPPPGKPADDAGLV |
| Molecular mass | ~1419 Da | Neutral form |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Typical storage | -20 C | Dry powder, protected from moisture |
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
==== MeSH D12.776.860.300.250 – collagen ==== MeSH D12.776.860.300.250.300 – fibrillar collagens MeSH D12.776.860.300.250.300.100 – Type I collagen MeSH D12.776.860.300.250.300.200 – Type II collagen MeSH D12.776.860.300.250.300.300 – Type III collagen MeSH D12.776.860.300.250.300.400 – Type V collagen MeSH D12.776.860.300.250.300.500 – Type XI collagen MeSH D12.776.860.300.250.400 – non-fibrillar collagens MeSH D12.776.860.300.250.400.100 – Type IV collagen MeSH D12.776.860.300.250.400.200 – Type VI collagen MeSH D12.776.860.300.250.400.300 – Type VII collagen MeSH D12.776.860.300.250.400.400 – Type VIII collagen MeSH D12.776.860.300.250.400.500 – Type X collagen MeSH D12.776.860.300.250.400.525 – Type XIII collagen MeSH D12.776.860.300.250.400.537 – Type XVIII collagen MeSH D12.776.860.300.250.400.537.500 – endostatins MeSH D12.776.860.300.250.400.550 – fibril-associated collagens MeSH D12.776.860.300.250.400.550.200 – Type IX collagen MeSH D12.776.860.300.250.400.550.300 – Type XII collagen MeSH D12.776.860.300.250.600 – procollagen MeSH D12.776.860.300.250.700 – tropocollagen
==== Chronic pain ==== It is also used in the management of chronic pain. Often, transdermal patches are used. The patches work by slowly releasing fentanyl through the skin into the bloodstream over 48 to 72 hours, allowing for long-lasting pain management. Dosage is based on the size of the patch, since, in general, the transdermal absorption rate is constant at a constant skin temperature. Each patch should be changed every 72 hours. Rate of absorption is dependent on a number of factors. Body temperature, skin type, amount of body fat, and placement of the patch can have major effects. The different delivery systems used by different makers will also affect individual rates of absorption, and route of administration. Under normal circumstances, the patch will reach its full effect within 12 to 24 hours; thus, fentanyl patches are often prescribed with a fast-acting opioid (such as morphine or oxycodone) to handle breakthrough pain. It is unclear if fentanyl gives long-term pain relief to people with neuropathic pain.
=== Trace gas analysis === One of the first papers reporting the use of the flowing afterglow studied ion-molecule reactions pertinent to the Martian atmosphere. This flowing afterglow technique replaced the then standard stationary afterglow when the movable Langmuir probe was introduced. The flowing afterglow has many attractive aspects: well-understood laminar behavior, viscous gas flow, a large density of carrier gas which allows the study of thermalized reactions, and the capability to make new reactant ions in situ. The ambipolar plasma is sampled using a nosecone and detected using conventional quadrupole or tandem mass spectrometry, depending on the application. One of the drawbacks of the flowing afterglow technique is the possibility of generating multiple reactant ions. This problem is circumvented by implementing the selected ion flow tube (SIFT). The flowing afterglow technique can be used to identify and quantify the volatile organic compounds (VOCs) of a sample as long as the fundamental ion chemistry is known. The commonly used ions are H3O+, O2+*, and NO+. All ions have drawbacks and advantages. Strategies that have been employed to identify the VOCs include using gas chromatography coupled with flowing afterglow and using a complement of reagent ions. Also in addition to being able to detect volatile organic compounds, the flowing afterglow technique has also been used to study chronic kidney disease.
==== Federal and large-scale ==== Several different organizations exist to mitigate and respond to food distribution crises in the United States. Prominent contributors to large-scale food distribution effort in the US include the Federal Emergency Management Agency (FEMA), United States Department of Agriculture (USDA), and Salvation Army. FEMA and the USDA work together during food distribution crises to coordinate the procurement and transportation of nonperishable food, water, and other resources to afflicted areas. The Salvation Army receives federal supplies from FEMA and the USDA, and then works on the local level to distribute necessary goods. All food given to civilians during a crisis is typically distributed at mass emergency feeding stations.
According to a study by Colombia's National Centre for Historical Memory, 220,000 people died in the conflict between 1958 and 2013, most of them civilians (177,307 civilians and 40,787 fighters), and more than five million civilians were forced from their homes between 1985 and 2012, generating the world's second-largest population of internally displaced persons (IDPs). 16.9% of the population in Colombia has been a direct victim of the war. 2.3 million children have been displaced from their homes and 45,000 children have been killed, according to national figures cited by UNICEF. In total, one in three of the 7.6 million registered victims of the conflict are children and 8,000 minors have disappeared since 1985. A Special Unit was created to search for persons deemed as missing within the context of and due to the armed conflict. As of April 2022, the Single Registry of Victims reported 9,263,826 victims of the Colombian conflict, with 2,048,563 of them being children. Approximately 80% of those killed in the conflict have been civilians. In 2022, the Truth Commission of Colombia estimated that paramilitaries were responsible for 45% of civilian deaths, the guerrillas for 27%, and state forces for 12%, with the remaining 16% attributable to other groups or mixed responsibility. On June 23, 2016, the Colombian government and the FARC rebels signed a historic ceasefire deal, bringing them closer to ending more than five decades of conflict.
Sources: en.wikipedia.org
==== Urea cycle ==== In the urea cycle, ornithine is converted to citrulline, then to arginine, and finally (through cleavage of urea) back to ornithine. The cycle is necessary because direct conversion of ammonia into urea is not possible under physiological conditions. Carbamoyl phosphate is formed from ammonia and carbon dioxide and enters the cycle. The carbon and one nitrogen atom are incorporated into urea, while the second nitrogen atom is derived from aspartate. Urea is produced in the liver and transported via the bloodstream to the kidney, where it is excreted in the urine. In urine, urea accounts for approximately 90% of the nitrogen content. In the mitochondrion, ornithine is converted with carbamoyl phosphate to citrulline by ornithine transcarbamoylase. The subsequent reactions occur in the cytosol. Citrulline and aspartic acid are converted by argininosuccinate synthase to argininosuccinate. This compound is then converted to arginine by argininosuccinate lyase, releasing fumarate. Arginine can subsequently be converted back to ornithine by arginase with the release of urea, thereby completing the cycle. Nitrogen excretion in the form of urea occurs in mammals, whereas fish typically excrete ammonium directly, and reptiles and birds excrete uric acid.
Folic acid: Low plasma concentrations of folic acid were found to be associated with high plasma homocysteine concentrations. In clinical trials, homocysteine concentrations were effectively reduced within 4 to 6 weeks of oral supplementation of folic acid. Moreover, since the activity of endothelial NO synthase enzyme might be potentially elevated by folate, folate supplementation might be capable of restoring the availability of NO in endothelium, therefore, improving endothelial function and reducing the risk for atherosclerosis. van Etten et al., found that a single dose of folic acid might help in reducing the risk of vascular complications and enhancing endothelial function in adults with type 2 diabetes by improving nitric oxide status.
This complexity makes it difficult to identify the interactions between individual components and to explore their basic biological functions. In vitro work simplifies the system under study, so the investigator can focus on a small number of components. For example, the identity of proteins of the immune system (e.g. antibodies), and the mechanism by which they recognize and bind to foreign antigens would remain very obscure if not for the extensive use of in vitro work to isolate the proteins, identify the cells and genes that produce them, study the physical properties of their interaction with antigens, and identify how those interactions lead to cellular signals that activate other components of the immune system.
== Confession, arrest, and conviction == Wettlaufer entered an inpatient drug rehabilitation program at the Centre for Addiction and Mental Health (CAMH) in Toronto, on September 16, 2016. There, she confessed to CAMH staff about killing or attempting to kill her patients, leading to CAMH notifying the College of Nurses of Ontario (CNO) and the Toronto Police Service. She then emailed CNO to resign as a registered nurse because she had "deliberately harmed patients in [her] care and [was] now being investigated by the police for same", personally called an investigator from CNO, and had CAMH staff fax a four-page handwritten confession. Wettlaufer had confessed to killing patients several times prior to her confession at CAMH, including to a lawyer who advised her to keep it a secret, and was not reported to police. After providing police with a two-hour-long confession, she was formally charged with the eight murders on October 25. After further investigation, she was also charged with four counts of attempted murder and two counts of aggravated assault on January 13, 2017. Wettlaufer waived her right to a preliminary hearing and confessed to all charges in court on June 1. On June 26, she was sentenced to eight concurrent life terms in prison, with no possibility of parole for 25 years. In her confession, Wettlaufer admitted that she "knew the difference between right and wrong" but she was visited by "surges" she could not control. She said, "God or the devil or whatever, wanted me to do it." After one murder, she felt "the surging ...
Don Cossacks (Russian: Донские казаки, romanized: Donskiye kazaki, Ukrainian: Донські козаки, romanized: Donski kozaky) or Donians (Russian: донцы, romanized: dontsy, Ukrainian: донці, romanized: dontsi), are Cossacks who settled along the middle and lower Don. Historically, they lived within the former Don Cossack Host (Russian: Донское казачье войско, romanized: Donskoe kazache voysko, Ukrainian: Головне Донське військо, romanized: Holovne Dons'ke viis'ko), which was either an independent or an autonomous democratic polity in present-day Southern Russia and parts of the Donbas region of Ukraine, from the end of the 16th century until 1918. As of 1992, by presidential decree of the Russian Federation, Cossacks can be enrolled on a special register. A number of Cossack communities have been reconstituted to further Cossack cultural traditions, including those of the Don Cossack Host. Don Cossacks have had a rich military tradition—they played an important part in the historical development of the Russian Empire and participated in most of its major wars.
Sources: en.wikipedia.org
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.
No. The gastric protein is larger, while BPC-157 is a short fragment sequence. The peptide is produced synthetically for research use. The relationship is one of sequence origin, not chemical identity.
It is most often supplied as a lyophilized powder, frequently as the acetate salt. The powder is reconstituted with water or a buffer before use. Free-base and other salt forms also exist but are less common in catalogs.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.